cyclopentane has been researched along with zinostatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bingham, JP; Caddick, S; Frost, LM; Hartley, JA; Kelland, LR; Urbaniak, MD; Woolfson, DN | 1 |
| Altboum, I; Fingrut, O; Flescher, E; Goldin, N; Reischer, D; Rotem, R; Zan-Bar, I | 1 |
2 other study(ies) available for cyclopentane and zinostatin
| Article | Year |
|---|---|
Chemical synthesis and cytotoxicity of dihydroxylated cyclopentenone analogues of neocarzinostatin chromophore.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cyclopentanes; Drug Screening Assays, Antitumor; Enediynes; HT29 Cells; Humans; Hydroxylation; Inhibitory Concentration 50; K562 Cells; Zinostatin | 2003 |
Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells.
Topics: Acetates; Adenosine Triphosphate; Antibiotics, Antineoplastic; Bleomycin; Cell Survival; Clone Cells; Cyclopentanes; Deoxyglucose; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Immunoblotting; Lymphoma, B-Cell; Mutation; Oligomycins; Oxylipins; Plant Growth Regulators; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Zinostatin | 2005 |